Trademark: REGOXIDINE
Put your brand on the blockchain and timestamp its proof of existence at wikitrademarks.io
Mark Identification
Proof of use for REGOXIDINE
We do not have any records of a proof of use for REGOXIDINE at this moment.
Possible trademark infringements of REGOXIDINE
Basic Information about REGOXIDINE
- Serial Number
- 88623032
- Filing Date
- 19 Sep 2019
- Registration Number
- 6055145
- Registration Date
- 12 May 2020
- Mark Drawing Code
- 3
Classifications
Declare the trademark use of REGOXIDINE on the blockchain with WikiTrademarks.io.
- First use of REGOXIDINE anywhere
- REGOXIDINE was first used on 03 May 2019 for the primary classification of goods and services, international, 005 (Pharmaceuticals)
- First use in commerce
- There is no first use of this trademark in commerce detected yet.
- Status Code
- 6
- International Code
- 005
- US Codes
- 006; 018; 044; 046; 051; 052
Who owns REGOXIDINE?
1. Innovus Pharmaceuticals, Inc. Denver CO
2. Innovus Pharmaceuticals, Inc. San Diego CA
3. Innovus Pharmaceuticals, Inc. San Diego CA
Correspondent
- Innovus Pharmaceuticals, Inc.
- 7900 E. Union Avenue
- Denver, CO 80237
- United States
Put your brand on the blockchain and timestamp its proof of existence at Wikitrademarks.io